← Back to HOWL

Werewolf Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 31/07/2026Mar 2026Filed 31/07/2026Sep 2025Filed 04/11/2025Jun 2025Filed 31/07/2026Mar 2025Filed 31/07/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025
$3.7−$14−$16−$18−$18−$17−$17−$16
$0.08−$0.28−$0.36−$0.40−$0.40−$0.38−$0.43−$0.39
4949464545444442

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.